Literature DB >> 21911696

Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene.

Neeraj Kumar1, Bradley F Boeve, Brendon P Boot, Carolyn F Orr, Joseph Duffy, Bryan K Woodruff, Anil K Nair, Jay Ellison, Karen Kuntz, Kejal Kantarci, Clifford R Jack, Barbara F Westmoreland, Julie A Fields, Matthew Baker, Rosa Rademakers, Joseph E Parisi, Dennis W Dickson.   

Abstract

OBJECTIVE: To report the clinical, electroencephalographic, and neuroradiologic findings in a kindred with a novel insertion in the prion protein gene, PRNP.
DESIGN: Clinical description of a kindred.
SETTING: Mayo Clinic Alzheimer Disease Research Center (Rochester, Minnesota).
SUBJECTS: Two pathologically confirmed cases and their relatives. MAIN OUTCOME MEASURES: Clinical features, electroencephalographic patterns, magnetic resonance imaging abnormalities, genetic analyses, and neuropathologic features.
RESULTS: The proband was a woman with clinical and neuroimaging features of atypical frontotemporal dementia and ataxia. Generalized tonic-clonic seizures developed later in the disease course, and electroencephalography revealed spike and wave discharges but no periodic sharp-wave complexes. Her affected sister and father also exhibited frontotemporal dementia-like features, and both experienced generalized tonic-clonic seizures and gait ataxia late in the disease course. Genetic analyses in the proband identified a novel defect in PRNP, with 1 mutated allele carrying a 288-base pair insertion consisting of 12 octapeptide repeats. Neuropathologic examination of the proband and her sister revealed prion protein-positive plaques and widespread tau-positive tangles.
CONCLUSIONS: This kindred has a unique combination of clinical and neuropathologic features associated with the largest base pair insertion identified to date in PRNP and underscores the need to consider familial prion disease in the differential diagnosis of a familial frontotemporal dementia-like syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911696      PMCID: PMC3326586          DOI: 10.1001/archneurol.2011.187

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  26 in total

1.  Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family.

Authors:  S Capellari; C Vital; P Parchi; R B Petersen; X Ferrer; D Jarnier; E Pegoraro; P Gambetti; J Julien
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

2.  The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system.

Authors:  T Kitamoto; K Doh-ura; T Muramoto; M Miyazono; J Tateishi
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

3.  Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies.

Authors:  M Poulter; H F Baker; C D Frith; M Leach; R Lofthouse; R M Ridley; T Shah; F Owen; J Collinge; J Brown
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

4.  Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features.

Authors:  J Collinge; J Brown; J Hardy; M Mullan; M N Rossor; H Baker; T J Crow; R Lofthouse; M Poulter; R Ridley
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

5.  Insert mutation in Creutzfeldt-Jakob disease.

Authors:  K Kenney; P Brown; B Little
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

6.  Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene.

Authors:  J L Laplanche; K H Hachimi; I Durieux; P Thuillet; L Defebvre; N Delasnerie-Lauprêtre; K Peoc'h; J F Foncin; A Destée
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

7.  Mutations of the prion protein gene phenotypic spectrum.

Authors:  Gábor G Kovács; Gianriccardo Trabattoni; Johannes A Hainfellner; James W Ironside; Richard S G Knight; Herbert Budka
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

Review 8.  Prion encephalopathy with insertion of octapeptide repeats: the number of repeats determines the type of cerebellar deposits.

Authors:  C Vital; F Gray; A Vital; P Parchi; S Capellari; R B Petersen; X Ferrer; D Jarnier; J Julien; P Gambetti
Journal:  Neuropathol Appl Neurobiol       Date:  1998-04       Impact factor: 8.090

9.  High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Authors:  D Galasko; L Chang; R Motter; C M Clark; J Kaye; D Knopman; R Thomas; D Kholodenko; D Schenk; I Lieberburg; B Miller; R Green; R Basherad; L Kertiles; M A Boss; P Seubert
Journal:  Arch Neurol       Date:  1998-07

10.  Dementia associated with a 216 base pair insertion in the prion protein gene. Clinical and neuropathological features.

Authors:  L W Duchen; M Poulter; A E Harding
Journal:  Brain       Date:  1993-06       Impact factor: 13.501

View more
  15 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

3.  MRS in early and presymptomatic carriers of a novel octapeptide repeat insertion in the prion protein gene.

Authors:  Eric M McDade; Bradley F Boeve; Julie A Fields; Neeraj Kumar; Rosa Rademakers; Matt C Baker; Bsc David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2012-05-21       Impact factor: 2.486

4.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

Review 5.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

6.  A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.

Authors:  Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero
Journal:  J Neurol       Date:  2012-07-05       Impact factor: 4.849

Review 7.  Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge.

Authors:  Zhongyun Chen; Min Chu; Li Liu; Jing Zhang; Yu Kong; Kexin Xie; Yue Cui; Hong Ye; Junjie Li; Lin Wang; Liyong Wu
Journal:  Alzheimers Res Ther       Date:  2022-06-29       Impact factor: 8.823

Review 8.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

Review 9.  Biology and genetics of prions causing neurodegeneration.

Authors:  Stanley B Prusiner
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

10.  Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation.

Authors:  Martin Paucar; Fengqing Xiang; Richard Moore; Ruth Walker; Elisabeth Winnberg; Per Svenningsson
Journal:  Prion       Date:  2013-11-25       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.